Bradley Glover
Chief Operating Officer at IMUGENE LIMITED
Net worth: 107 815 $ as of 2024-04-29
Bradley Glover active positions
Companies | Position | Start | End |
---|---|---|---|
IMUGENE LIMITED | Chief Operating Officer | 2023-08-20 | - |
Career history of Bradley Glover
Former positions of Bradley Glover
Companies | Position | Start | End |
---|---|---|---|
CELULARITY INC. | Chief Operating Officer | 2022-10-03 | 2023-05-30 |
Chief Tech/Sci/R&D Officer | 2021-07-15 | 2022-10-03 | |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Chief Tech/Sci/R&D Officer | 2021-02-28 | - |
KITE PHARMA INC | Corporate Officer/Principal | 2016-08-31 | - |
Training of Bradley Glover
The University of Colorado | Doctorate Degree |
Rady School of Management at UC San Diego | Masters Business Admin |
University of California San Diego | Undergraduate Degree |
Statistics
International
United States | 7 |
Australia | 2 |
Operational
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Consumer Services | 4 |
Commercial Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CELULARITY INC. | Commercial Services |
IMUGENE LIMITED | Health Technology |
Private companies | 2 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
- Stock Market
- Insiders
- Bradley Glover
- Experience